Researchers Develop a Versatile Bioorthogonal Theranostic Platform for Precision Cancer Therapy

Targeted protein degradation (TPD) has revolutionized drug discovery by enabling selective elimination of previously ‘undruggable’ proteins through molecular glue degraders (M...

Study Develops Human-Derived AMBER Editor for Efficient C-to-U RNA Editing in vivo

In a study published in National Academy of Sciences of the United States of America (PNAS), a research team led by HAO Pei from the Shanghai Institute of Materia Medica, Chines...

Researchers Decode Selective and Dual Blocking of Prostaglandin Receptors EP2 and EP4

Prostaglandin E2 (PGE2), a key lipid mediator, drives inflammation, pain, and cancer progression by activating four G protein-coupled receptors (GPCRs): EP1–EP4. Among these, E...